Whalegun
Home

Andrew J. Schwab, 10% Owner: Enliven Therapeutics ELVN Sell · Filed 24/02/02

Trade details

Type
Insider sale
Amount
$6,257,805
Shares · price
417,187 sh · $15.00 a share
Held after
3,888,992 sh
Stock
Enliven Therapeutics ELVN
Person
Andrew J. Schwab10% Owner
Trade date
24/01/31
Filed
24/02/02
Days to filing
2 days

Sold 9.7% of holdings

Share of holding sold
9.7%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/01~24/03/01

Andrew J. Schwab's recent trades

  • Andrew J. Schwab

    SellSkye Bioscience

    $184.9K

    Filed 09/24

  • Andrew J. Schwab

    SellSkye Bioscience

    $45.6K

    Filed 09/24

  • Andrew J. Schwab

    SellSkye Bioscience

    $7,290

    Filed 09/24

  • Andrew J. Schwab

    SellSkye Bioscience

    $1,795

    Filed 09/24

  • Andrew J. Schwab

    SellEntrada Therapeutics

    $1.8M

    Filed 25/11/18

Andrew J. Schwab, 10% Owner — sold $6.3M of Enliven Therapeutics ELVN · 9.7% of holdings | Whalegun